CTNI-22. A PHASE 0/2 ‘TRIGGER’ TRIAL OF NIRAPARIB IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA

Authors: Nader Sanai, Tigran Margaryan, Jennifer Molloy, Hualin Zhang, William Knight, Jocelyn Harmon, Amy Hong, John Wanebo, William Kennedy, Kelly Braun, Michael Garcia, Igor Barani, Wonsuk Yoo, An-Chi Tien, Artak Tovmasyan, Shwetal Mehta

Published: 2023-11-11

DOI: 10.1093/neuonc/noad179.0304

Source: Full article

CTNI-22. A PHASE 0/2 ‘TRIGGER’ TRIAL OF NIRAPARIB IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA

Abstract